This archive contains the following articles listed by volume, issue and page number:
 |
|
|
Volume 13, 2009 Articles |
Title (Click for Details) |
Vol/Issue |
Page |
PreScription: A New Start: What Will 2009 Bring? |
Vol. 13 No. 1 |
4 |
Compounding for Pediatric Patients: Case Reports and Formulations |
Vol. 13 No. 1 |
6 |
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports |
Vol. 13 No. 1 |
14 |
Compounding for Manufacturer Backorders and Discontinuations: "Oh, No! Not Again!" |
Vol. 13 No. 1 |
20 |
Compounding with Sucralfate for the Treatment of External Wounds |
Vol. 13 No. 1 |
25 |
Identifying the Criteria of a Valid Stability Study |
Vol. 13 No. 1 |
32 |
Summertime in an American Apothecary Garden |
Vol. 13 No. 1 |
38 |
Compounding for Cancer in Companion Animals |
Vol. 13 No. 1 |
42 |
Technology for the Compounding Pharmacy: Digital Pens--Tools or Toys? |
Vol. 13 No. 1 |
50 |
Quality Control Analytical Methods: Testing of Electrolytes Solutions |
Vol. 13 No. 1 |
53 |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs |
Vol. 13 No. 1 |
56 |
Calculations |
Vol. 13 No. 1 |
63 |
Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets |
Vol. 13 No. 1 |
64 |
Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder |
Vol. 13 No. 1 |
65 |
Dextromethorphan Hydrobromide 10% and Guaifenesin 10% Rapidly Penetrating Gel |
Vol. 13 No. 1 |
66 |
Dextromethorphan Hydrobromide 30-mg Troches |
Vol. 13 No. 1 |
67 |
Diaper Rash Cream with Miconazole |
Vol. 13 No. 1 |
68 |
Diphenhydramine Hydrochloride 25-mg Gelatin Troches |
Vol. 13 No. 1 |
69 |
Electrolyte Lollipop (Adult) |
Vol. 13 No. 1 |
70 |
Hydrogen Peroxide 1.5% and Sodium Fluoride 0.5-mg/mL Oral Rinse |
Vol. 13 No. 1 |
71 |
Peruvian Balsam, Zinc Stearate, Boric Acid, and Talcum Powder |
Vol. 13 No. 1 |
72 |
Tetracaine 0.025% Popsicles |
Vol. 13 No. 1 |
73 |
Testing of Estradiol in a Compounded Cream and a Stock Solution |
Vol. 13 No. 1 |
74 |
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration |
Vol. 13 No. 1 |
78 |
The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials |
Vol. 13 No. 1 |
81 |
PostScription: The Compounding Pharmacy in Brazil: A Pharmacist's Perspective |
Vol. 13 No. 1 |
87 |
PreScription: Electronic Prescribing |
Vol. 13 No. 2 |
92 |
Compliance by Hospitals and Healthcare Facilities with the Revised United States Pharmacopeia Chapter <797> |
Vol. 13 No. 2 |
94 |
Tips for Cleanroom Construction and Renovation |
Vol. 13 No. 2 |
100 |
Contract Sterilization and Validation Companies Offer New Options for Sterile Compounded Preparations |
Vol. 13 No. 2 |
106 |
Treating Methicillin-Resistant Staphylococcus Aureus Infections with Compounded Vancomycin Preparations |
Vol. 13 No. 2 |
120 |
Compendial Activities Relating to Cold Chain Management Issues: Drug Products and Compounded Preparations |
Vol. 13 No. 2 |
128 |
Incorporating Web Communication to Maximize Staff Productivity in a Compounding Pharmacy |
Vol. 13 No. 2 |
138 |
Blogging for Business |
Vol. 13 No. 2 |
141 |
Quality-Control Analytical Methods: Compounding Slow-Release Pharmaceuticals |
Vol. 13 No. 2 |
144 |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 12: Sterilization Methods |
Vol. 13 No. 2 |
146 |
Calculations |
Vol. 13 No. 2 |
151 |
Acidified Sodium Hypochlorite for Antisepsis and Disinfection |
Vol. 13 No. 2 |
152 |
Aprepitant 20-mg/mL Oral Liquid |
Vol. 13 No. 2 |
153 |
Chloroquine Phosphate 64.5-mg/mL Injection |
Vol. 13 No. 2 |
154 |
Doxorubicin Hydrochloride 1-mg/mL in Sodium Chloride Solution Intravesical Instillation |
Vol. 13 No. 2 |
155 |
Ionic Hydration Solution for Anti-Cancer Therapy |
Vol. 13 No. 2 |
156 |
Metronidazole 2.1-mg/mL in 5.25% Dextrose Injection |
Vol. 13 No. 2 |
157 |
Nicotine Rectal Enema |
Vol. 13 No. 2 |
158 |
Thiothixene Hydrochloride 2-mg/mL Injection |
Vol. 13 No. 2 |
159 |
Tolterodine 2-mg/5-mL Oral Suspension |
Vol. 13 No. 2 |
160 |
Vasopressin Tannate 5 Pressor Units Per mL in Oil Injection |
Vol. 13 No. 2 |
161 |
Drug Compatibility with a New Generation of VISIV Polyolefin Infusion Solution Containers |
Vol. 13 No. 2 |
162 |
Stability of Low-Concentration Ceftazidime in 0.9% Sodium Chloride Injection and Balanced Salt Solutions in Plastic Syringes Under Various Storage Conditions |
Vol. 13 No. 2 |
166 |
Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule |
Vol. 13 No. 2 |
170 |
PostScription: Compounding in Argentina |
Vol. 13 No. 2 |
175 |
PreScription: A Good Name: Pharmacy |
Vol. 13 No. 3 |
180 |
Update on Managing Neuropathic Pain |
Vol. 13 No. 3 |
182 |
Elegant Compounded Solutions for the Treatment of Thrombosed External Hemorrhoids |
Vol. 13 No. 3 |
192 |
Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report |
Vol. 13 No. 3 |
196 |
Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers |
Vol. 13 No. 3 |
214 |
Safe Use of Topical Local Anesthetic Medications for Pain Management |
Vol. 13 No. 3 |
218 |
Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report |
Vol. 13 No. 3 |
220 |
Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education |
Vol. 13 No. 3 |
224 |
Quality-Control Analytical Methods: Pharmaceutical and Analytical Considerations of the Significance of pH |
Vol. 13 No. 3 |
230 |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control |
Vol. 13 No. 3 |
234 |
Calculations |
Vol. 13 No. 3 |
239 |
Analgesic Compound Lotion, Clear |
Vol. 13 No. 3 |
240 |
Hydromorphone Hydrochloride 10-mg/mL Oral Drops |
Vol. 13 No. 3 |
241 |
Lidocaine 2% Popsicle |
Vol. 13 No. 3 |
242 |
Morphine Sulfate 10-mg/mL Oral Solution |
Vol. 13 No. 3 |
243 |
Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel |
Vol. 13 No. 3 |
244 |
Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel |
Vol. 13 No. 3 |
245 |
Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules |
Vol. 13 No. 3 |
246 |
Oxycodone Hydrochloride 20-mg Suppository |
Vol. 13 No. 3 |
247 |
Promethazine 20-mg and Acetaminophen 325-mg Suppositories |
Vol. 13 No. 3 |
248 |
Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules |
Vol. 13 No. 3 |
249 |
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding |
Vol. 13 No. 3 |
250 |
Stability of Pergolide Mesylate Oral Liquid at Room Temperature |
Vol. 13 No. 3 |
254 |
Formulation Optimization Study for an Immediate-Release Tablet |
Vol. 13 No. 3 |
259 |
PostScription: Compounding in Israel |
Vol. 13 No. 3 |
262 |
PreScription: Trust |
Vol. 13 No. 4 |
268 |
The Physiologic Role and Use of Estriol |
Vol. 13 No. 4 |
270 |
Hormone Treatment Options for Males: What to Do for Men with Low Testosterone |
Vol. 13 No. 4 |
276 |
Saliva Tests, Part 1: Clinical Use, Elements of Testing, and Guidelines for Posttreatment Interpretation |
Vol. 13 No. 4 |
280 |
Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients |
Vol. 13 No. 4 |
290 |
Compounding Naltrexone for the Treatment of Autism |
Vol. 13 No. 4 |
296 |
Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting |
Vol. 13 No. 4 |
300 |
Optimizing Your Website: Search Engine Optimization, Pay Per Click, Email Marketing |
Vol. 13 No. 4 |
311 |
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding |
Vol. 13 No. 4 |
314 |
Quality-Control Analytical Methods: Quality Control, Quality Assurance, and Quality Improvement--What is the Difference and Why Should Compounding Pharmacies Care? |
Vol. 13 No. 4 |
318 |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued) |
Vol. 13 No. 4 |
322 |
Calculations |
Vol. 13 No. 4 |
330 |
Alcohol-based Carbomer Gel |
Vol. 13 No. 4 |
332 |
Benzoyl Peroxide 10% Gel |
Vol. 13 No. 4 |
333 |
Clindamycin 100-mg Vaginal Suppositories |
Vol. 13 No. 4 |
334 |
Dexamethasone and Furosemide Injection |
Vol. 13 No. 4 |
335 |
Instant Voice |
Vol. 13 No. 4 |
336 |
Moxifloxacin 20-mg/mL Oral Liquid |
Vol. 13 No. 4 |
337 |
Mupirocin 1% (20-mg) Vaginal Suppository |
Vol. 13 No. 4 |
338 |
Riley Butt Cream |
Vol. 13 No. 4 |
339 |
Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil |
Vol. 13 No. 4 |
340 |
Trolamine Oleate Otic Solution |
Vol. 13 No. 4 |
341 |
Quality of Progesterone Suppositories Prepared by FIRST-Progesterone VGS 50 Kit or Traditional Compounding Method: In Vitro Comparison |
Vol. 13 No. 4 |
342 |
Women's Perspective on Progesterone: A Qualitative Study Conducted in Australia |
Vol. 13 No. 4 |
345 |
PostScription: Compounding Pharmacy in Puerto Rico |
Vol. 13 No. 4 |
350 |
PreScription: Veterinary Pharmacy |
Vol. 13 No. 5 |
356 |
Transdermal Dosing Considerations for Veterinarians |
Vol. 13 No. 5 |
358 |
Little Thief: The Domestic Ferret |
Vol. 13 No. 5 |
362 |
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret |
Vol. 13 No. 5 |
367 |
A Review of Stomatitis and Treatment in Cats |
Vol. 13 No. 5 |
372 |
Azithromycin in the Treatment of Pneumonic Foals |
Vol. 13 No. 5 |
382 |
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses |
Vol. 13 No. 5 |
386 |
Recommended Tips for Treating Veterinary Patients |
Vol. 13 No. 5 |
390 |
Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing |
Vol. 13 No. 5 |
392 |
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications |
Vol. 13 No. 5 |
400 |
An Abridged History of Aspirin |
Vol. 13 No. 5 |
404 |
Marketing Veterinarians |
Vol. 13 No. 5 |
410 |
Quality-Control Analytical Methods: Designing a Quality-Control Potency Testing Program for a Compounding Pharmacy |
Vol. 13 No. 5 |
412 |
Calculations |
Vol. 13 No. 5 |
419 |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chater <797> Pharmaceutical Compounding--Sterile Preparations, Part 15: Personnel Training, Cleansing, and Garbing |
Vol. 13 No. 5 |
420 |
Aceclofenac 1.5% Pluronic Lecithin Organogel |
Vol. 13 No. 5 |
428 |
Amlodipine Besylate 1 mg/mL Veterinary Suspension |
Vol. 13 No. 5 |
429 |
Cooling Ointment |
Vol. 13 No. 5 |
430 |
Emanuel Butt Paste |
Vol. 13 No. 5 |
431 |
Ferric Pyrophosphate 50-mg/mL Solution for Iontophoresis |
Vol. 13 No. 5 |
432 |
Lidocaine 10% Oral Pluronic Lecithin Organogel |
Vol. 13 No. 5 |
433 |
Mechlorethamine Hydrochloride 0.02% Topical |
Vol. 13 No. 5 |
434 |
Myristyl Nicotinate 5% Topical Gel |
Vol. 13 No. 5 |
435 |
Nitroglycerin 4-mg Suppository |
Vol. 13 No. 5 |
436 |
Zonisamide 10-mg/mL Oral Suspension |
Vol. 13 No. 5 |
437 |
Chemical Stability of Scopolamine Hydrobromide Nasal Solution |
Vol. 13 No. 5 |
438 |
Compounding Solutions for Exotic and Nondomesticated Fauna in Australia: An Investigative Study |
Vol. 13 No. 5 |
440 |
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms |
Vol. 13 No. 5 |
445 |
PostScription: Setting up a National System of Compounding Pharmacies: An Introduction |
Vol. 13 No. 5 |
447 |
PreScription: Geriatric Compounding: An Opportunity for Pharmacists |
Vol. 13 No. 6 |
492 |
Low Testosterone in Older Men: A Discussion and Review of Literature on Health Consequences of Hypogonadism in the Aging Male |
Vol. 13 No. 6 |
494 |
Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms |
Vol. 13 No. 6 |
498 |
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis |
Vol. 13 No. 6 |
506 |
Urinary Deoxypyridinoline Level Reveals Bone Resorption, Predicts Fracture Risk, and Enhances the Results of Dual Energy X-Ray Absorptiometry |
Vol. 13 No. 6 |
516 |
An Overview of United States Pharmacopeia Chapter <795> and American Society of Health-System Pharmacists Guidelines for Nonsterile Compounding |
Vol. 13 No. 6 |
525 |
Setting Up a National System of Compounding Pharmacies: Preventing Error, Assuring Quality, Building Trust |
Vol. 13 No. 6 |
532 |
Marketing the Geriatric Patient |
Vol. 13 No. 6 |
538 |
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops |
Vol. 13 No. 6 |
540 |
Calculations |
Vol. 13 No. 6 |
545 |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 16: Suggested Standard Operating Procedures |
Vol. 13 No. 6 |
546 |
Cidofovir 0.2-mg/mL Intravitreous Injection |
Vol. 13 No. 6 |
554 |
Fluconazole 2% Topical Microemulsion |
Vol. 13 No. 6 |
555 |
Gentian Violet Vaginal Suppositories |
Vol. 13 No. 6 |
556 |
Ichthammol 10% Otic Solution |
Vol. 13 No. 6 |
557 |
Lubow's Solution |
Vol. 13 No. 6 |
558 |
Miconazole 1% Ophthalmic Solution, Veterinary |
Vol. 13 No. 6 |
559 |
Topiramate 6-mg/mL Oral Suspension |
Vol. 13 No. 6 |
560 |
Twevan Cream |
Vol. 13 No. 6 |
561 |
Voriconazole 2% Ophthalmic Solution |
Vol. 13 No. 6 |
562 |
Wound Gel |
Vol. 13 No. 6 |
563 |
Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes |
Vol. 13 No. 6 |
564 |
The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel |
Vol. 13 No. 6 |
569 |
Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions |
Vol. 13 No. 6 |
572 |
PostScription: Compounding Seminar: International Pharmaceutical Federation Congress--Istanbul |
Vol. 13 No. 6 |
574 |